Classifying a GMP change as minor or major requires a documented assessment of its potential impact. The physical size or cost of a change does not reliably indicate its risk to product quality, validated status, regulatory commitments or data integrity.
Start with the change description
Define current state, proposed state, rationale, affected products, equipment, methods, records, suppliers and sites. Identify whether the change is temporary or permanent and whether linked systems or procedures are affected.
Impact assessment
Evaluate critical quality attributes, process parameters, validation, stability, specifications, cleaning, training, data integrity and regulatory submissions. Consult quality, regulatory, engineering, manufacturing and analytical specialists as appropriate.
Classification is site-specific
Minor and major labels depend on the approved quality-system definitions and regulatory framework. A change may be low operational risk yet require a regulatory variation, or be technically small but highly significant to data integrity. Do not use an arbitrary universal classification table.
Example: software calculation
Changing a laboratory spreadsheet formula may require independent verification, historical data impact assessment, user training and controlled deployment. A single-cell modification could alter released results and therefore warrants more scrutiny than its apparent size suggests.
Example: packaging component
Changing a carton supplier may appear straightforward, but evaluate artwork, print legibility, serialization, material specifications, line compatibility and regulatory commitments. Supplier qualification and incoming controls may need updating.
Implementation and effectiveness
Define testing, validation or qualification, approvals, training, document revisions and implementation timing before release of the change. Post-implementation checks should confirm the intended outcome and absence of new problems.
Change-control record
Retain impact assessment, risk rationale, supporting evidence, approval, regulatory determination, implementation records, deviations and closure. Significant unresolved actions should not be obscured by administrative closure.
References and related reading
For educational use. Apply current product-specific specifications, pharmacopoeial requirements and approved site procedures.


